Compare IQV & ESLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IQV | ESLT |
|---|---|---|
| Founded | 1982 | 1966 |
| Country | United States | Israel |
| Employees | 93000 | N/A |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Military/Government/Technical |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 35.1B | 35.2B |
| IPO Year | 2013 | 2002 |
| Metric | IQV | ESLT |
|---|---|---|
| Price | $247.64 | $769.10 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 16 | 3 |
| Target Price | $227.13 | ★ $667.00 |
| AVG Volume (30 Days) | ★ 1.3M | 65.4K |
| Earning Date | 05-05-2026 | 05-26-2026 |
| Dividend Yield | N/A | ★ 0.38% |
| EPS Growth | ★ 4.67 | N/A |
| EPS | ★ 1.61 | N/A |
| Revenue | ★ $9,739,000,000.00 | N/A |
| Revenue This Year | $6.77 | $14.29 |
| Revenue Next Year | $5.89 | $8.49 |
| P/E Ratio | $151.84 | ★ $71.88 |
| Revenue Growth | ★ 41.60 | N/A |
| 52 Week Low | $154.50 | $432.85 |
| 52 Week High | $247.72 | $1,016.06 |
| Indicator | IQV | ESLT |
|---|---|---|
| Relative Strength Index (RSI) | 80.75 | 49.11 |
| Support Level | $159.91 | $716.79 |
| Resistance Level | N/A | $821.25 |
| Average True Range (ATR) | 6.70 | 18.70 |
| MACD | 3.10 | 7.40 |
| Stochastic Oscillator | 92.37 | 52.12 |
Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.
Elbit Systems Ltd is a technology company involved in producing a portfolio of systems and products for aircraft, land, and naval applications. The company's products are used for defense, homeland security and commercial flight capabilities. Its systems and solutions may be installed on new platforms or it may perform a comprehensive modernization program to transform a platform. Elbit Systems gives instructions to its customers on the proper maintenance of its products and will provide support team specialists when the customer cannot fix a problem. The company operates in five segments: Aerospace; C4I and Cyber; ISTAR and EW; Land; and ESA. It derives maximum revenue from Land Segment. Geographically, it operates in Israel; North America; Europe; Asia-Pacific; Latin America; and Others.